Riedel, F.; Münker, M.; Roghmann, F.; Breyer, J.; Schnabel, M.J.; Burger, M.; Sikic, D.; Büttner, T.; Ritter, M.; Hiller, K.;
et al. Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment—A Retrospective Multicenter Analysis. Cancers 2022, 14, 2850.
https://doi.org/10.3390/cancers14122850
AMA Style
Riedel F, Münker M, Roghmann F, Breyer J, Schnabel MJ, Burger M, Sikic D, Büttner T, Ritter M, Hiller K,
et al. Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment—A Retrospective Multicenter Analysis. Cancers. 2022; 14(12):2850.
https://doi.org/10.3390/cancers14122850
Chicago/Turabian Style
Riedel, Felix, Mara Münker, Florian Roghmann, Johannes Breyer, Marco J. Schnabel, Maximilian Burger, Danijel Sikic, Thomas Büttner, Manuel Ritter, Kiriaki Hiller,
and et al. 2022. "Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment—A Retrospective Multicenter Analysis" Cancers 14, no. 12: 2850.
https://doi.org/10.3390/cancers14122850
APA Style
Riedel, F., Münker, M., Roghmann, F., Breyer, J., Schnabel, M. J., Burger, M., Sikic, D., Büttner, T., Ritter, M., Hiller, K., Wezel, F., Bolenz, C., & Zengerling, F.
(2022). Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment—A Retrospective Multicenter Analysis. Cancers, 14(12), 2850.
https://doi.org/10.3390/cancers14122850
